MedTrace Logo

Clinic-based ART Diagnostic Evaluation

NCT01791556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 820

Last updated 2023-12-15

No results posted yet for this study

Summary

The study is funded through the Office of the Global AIDS Coordinator (OGAC #KE-07-0044). The purpose of this study is two-fold. The first purpose is to see if routine monitoring of the level of HIV virus in the blood (viral load) every six months is superior to monitoring by standard clinical evaluations and or immune status (CD4 count) with intermittent viral load monitoring in adults receiving antiretroviral therapy (ART). The second purpose is to understand the cost implications and possible benefits of routine HIV viral load monitoring.

Conditions

  • Acquired Immunodeficiency Syndrome
  • HIV Infection
  • RNA Virus Infections
  • Virus Diseases

Interventions

OTHER

HIV-1 viral load testing

Sponsors & Collaborators

  • US Military HIV Research Program

    collaborator NETWORK

  • Kenya Medical Research Institute

    collaborator OTHER

  • Walter Reed Army Institute of Research (WRAIR)

    lead FED

Principal Investigators

  • Fredrick Sawe, MBChB, MMED · Kenya Medical Research Institute/ Walter Reed Project

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-26
Primary Completion
2011-03-25
Completion
2012-08-31

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791556 on ClinicalTrials.gov